+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-01-08Number of Pages: 86

Foot and Mouth Disease Vaccines Market (Types- Conventional (Aluminum Hydroxide/Saponin and Oil Based Vaccines) and Emergency Vaccines; Application - Cattle, Pigs, Sheep and Goat and Others - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Global Foot and Mouth Disease Vaccines Market: Snapshot

Foot and mouth disease (FMD) is a highly infectious viral disease that affects cloven-hoofed animals. The diseases is known to lead to high mortality rate among young livestock such as lambs and piglets and recurring endemics of the disease across the globe have a vast socioeconomic impact on the international trade related to livestock products. In the past few years, favorable government initiatives to control FMD outbreaks have significantly boosted the growth of the global FMD vaccines market. Moreover, the rising consumption of meat and dairy products across the globe has further fuelled the need for FMD vaccines.

The market features a highly fragmented competitive landscape and is largely controlled by various government bodies that purchase these vaccines in bulk directly from manufacturers. This scenario has made competition highly fierce in the market and is expected to bring about a significant dip in profit margins of companies operating in this market in the near future. Nevertheless, the budding and highly promising segment of DNA vaccines will open new opportunities for market players during the forecast period.

Transparency Market Research projects that the global foot and mouth disease vaccines market will exhibit a promising 8.8% CAGR over the period between 2014 and 2020. As a result, the market is expected to rise from a valuation of US$0.51 bn in 2013 to US$0.95 bn by 2020.

Vast Demand for Oil-based Vaccines to Continue to Keep Conventional Vaccines Most Promising

Depending upon the type of vaccines, the report segments the global FMD vaccines market into conventional vaccines and emergency vaccines. The segment of conventional vaccines has been further categorized into aluminum hydroxide- or Saponin-based vaccines and oil-based vaccines. Of these, the segment of oil-based FMD vaccines dominated, accounting for a massive 63% in the global market in 2013. Thus, the conventional vaccine segment leads the global FMD vaccine market and is expected to remain the dominant product segment over the report’s forecast period. The increasing adoption of routine vaccination programs to eradicate or control the disease spread will help the segment of conventional FMD vaccines to gain increased demand in the near future.

Asia Pacific to be Leading Regional Market for FMD Vaccines

From a geographical perspective, the report analyzes the market for FMD vaccines across region such as Asia Pacific, Europe, Africa, North America, and Latin America. Of these, the market across Asia Pacific is presently the dominant contributor of revenue to the global FMD vaccines market. The region is the leading consumer of FMD vaccines owing to the presence of some of countries such as South Korea, China, Bangladesh, Hong Kong, India, and Pakistan, which are most severely impacted by FMD endemics.

Apart from the promising demand across the Asia Pacific region, the demand for FMD vaccines is also expected to witness encouraging rise across countries such as Sudan, Egypt, and Brazil over the report’s forecast period owing to the rising outbreaks of FMD in these countries. Majority of countries in Western Europe, New Zealand, Australia, and countries in North America are FMD free and have no scope for FMD vaccines. As a result, the FMD vaccines market across these regions is expected to witness very low or no growth over the report’s forecast period.

The report states that the global FMD vaccines market features a highly fragmented vendor landscape owing to the presence of a large number of domestic vendors presenting fierce competition for global vendors. Moreover, several FMD endemic countries have their own government-initiated or funded FMD vaccine manufacturing facilities, restraining the entry or expansion of international vendors across such regions. Some of the key vendors operating in the market are Brilliant Bio Pharma Ltd, Bayer AG, Agrovet Co., Biogenesis Bago, Inova Biotecnologia, and Indian Immunologicals Ltd.

 
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
     1.3.1 Sources
             1.3.1.1 Secondary Research
             1.3.1.2 Primary Research
     1.3.2 Assumptions
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global FMD Vaccines Market (2013 and 2020)
2.2 Global FMD Vaccines Market Revenue, by Types, 2013 (USD Million)
2.3 Global FMD Vaccines Market Revenue, by Applications, 2013 (USD Million)
2.4 Comparative Analysis: Global FMD Vaccines Market, by Geography, 2013 & 2020 (Value %)
 
Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
     3.2.1 Favorable government initiatives boosts the demand of FMD vaccines
     3.2.2 Increasing consumption of meat and dairy products augments the demand of FMD vaccines
3.3 Market Restraints
     3.3.1 Government involvement in purchase of the vaccines result in reduction of cost
     3.3.2 Unpredictable serotype outbreaks limit the growth of the market
3.4 Market Opportunities
     3.4.1 DNA vaccines hold immense potential for foot and mouth disease
3.5 Regulatory Framework: Global FMD Vaccines Market
3.6 Value Chain Analysis: Global FMD Vaccines Market
3.7 Porter’s Five Forces Analysis: Global FMD Vaccines Market
     3.7.1 Bargaining power of suppliers
     3.7.2 Bargaining power of buyers
     3.7.3 Threat of substitutes
     3.7.4 Threat of new entrants
     3.7.5 Competitive rivalry
3.8 Market Attractiveness Analysis: Global FMD Vaccines Market, by Geography, 2013
3.9 Competitive Landscape
     3.9.1 Market Share Analysis: Global FMD Vaccines Market Share, by Key Players, 2013 (%)
 
Chapter 4 FMD Vaccines Market, by Types
4.1 Overview
     4.1.1 Global FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
4.2 Conventional Vaccines
     4.2.1 Global Conventional Vaccines Market Revenue, by Adjuvants, 2012 – 2020 (USD Million)
     4.2.2 Aluminum Hydroxide/Saponin based Vaccines
             4.2.2.1 Global Aluminum Hydroxide/Saponin based Vaccines Market, 2012 – 2020 (USD Million)
     4.2.3 Oil based Vaccines
             4.2.3.1 Global Oil based Vaccines Market, 2012 – 2020 (USD Million)
4.3 Emergency Vaccines
     4.3.1 Global Emergency Vaccines Market, 2012 – 2020 (USD Million)
 
Chapter 5 FMD Vaccines Market, by Applications
5.1 Overview
     5.1.1 Global FMD Vaccines Market Revenue, by Applications, 2012 – 2020 (USD Million)
5.2 Cattle
     5.2.1 Global Cattle Application Market, 2012 – 2020 (USD Million)
5.3 Pigs
     5.3.1 Global Pigs Application Market, 2012 – 2020 (USD Million)
5.4 Sheep and Goats
     5.4.1 Global Sheep and Goats Application Market, 2012 – 2020 (USD Million)
5.5 Others
     5.5.1 Global Others Application Market, 2012 – 2020 (USD Million)
 
Chapter 6 FMD Vaccines Market, by Geography
6.1 Overview
     6.1.1 Global FMD Vaccines Market Revenue, by Geography, 2012 - 2020 (USD Million)
6.2 North America
6.3 Europe
     6.3.1 Europe FMD Vaccines Market Revenue, by Types, 2012 - 2020 (USD Million)
6.4 Asia Pacific
     6.4.1 Asia Pacific FMD Vaccines Market Revenue, by Types, 2012 - 2020 (USD Million)
     6.4.2 Asia Pacific FMD Vaccines Market Revenue, by Country, 2012 - 2020 (USD Million)
     6.4.3 China
             6.4.3.1 China FMD Vaccines Market Revenue, by Types, 2012 - 2020 (USD Million)
     6.4.4 India
             6.4.4.1 India FMD Vaccines Market Revenue, by Types, 2012 - 2020 (USD Million)
     6.4.5 South Korea
             6.4.5.1 South Korea FMD Vaccines Market Revenue, by Types, 2012 - 2020 (USD Million)
     6.4.6 Malaysia
             6.4.6.1 Malaysia FMD Vaccines Market Revenue, by Country, 2012 - 2020 (USD Million)
     6.4.7 Rest of APAC
             6.4.7.1 Rest of APAC FMD Vaccines Market Revenue, by Types, 2012 - 2020 (USD Million)
6.5 Rest of the World (RoW)
     6.5.1 RoW FMD Vaccines Market Revenue, by Types, 2012 - 2020 (USD Million)
     6.5.2 RoW FMD Vaccines Market Revenue, by Country, 2012 - 2020 (USD Million)
     6.5.3 Latin America
             6.5.3.1 Latin America FMD Vaccines Market Revenue, by Types, 2012 - 2020 (USD Million)
     6.5.4 Africa
             6.5.4.1 Africa FMD Vaccines Market Revenue, by Country, 2012 - 2020 (USD Million)
             6.5.4.2 South Africa
                       6.5.4.2.1 South Africa FMD Vaccines Market Revenue, by Types, 2012 - 2020 (USD Million)
             6.5.4.3 Algeria
                       6.5.4.3.1 Algeria FMD Vaccines Market Revenue, by Types, 2012 - 2020 (USD Million)
             6.5.4.4 Nigeria
                       6.5.4.4.1 Nigeria FMD Vaccines Market Revenue, by Types, 2012 - 2020 (USD Million)
             6.5.4.5 Rest of Africa
                       6.5.4.5.1 Rest of Africa FMD Vaccines Market Revenue, by Types, 2012 - 2020 (USD Million)
     6.5.5 Rest of RoW
             6.5.5.1 Rest of RoW FMD Vaccines Market Revenue, by Types, 2012 - 2020 (USD Million)
 
Chapter 7 Recommendations
7.1 Investing in emerging economies
7.2 Long-term contracts with governments to expand market share
 
Chapter 8 Company Profiles
8.1 Agrovet Co.
     8.1.1 Company Overview
     8.1.2 Financial Overview
     8.1.3 Product Portfolio
     8.1.4 Business Strategies
8.2 Bayer AG
     8.2.1 Company Overview
     8.2.2 Financial Overview
     8.2.3 Product Portfolio
     8.2.4 Business Strategies
             8.2.4.3 Recent Developments
8.3 Biogenesis Bago
     8.3.1 Company Overview
     8.3.2 Financial Overview
     8.3.3 Product Portfolio
     8.3.4 Business Strategies
     8.3.5 Recent Developments
8.4 Brilliant Bio Pharma Limited
     8.4.1 Company Overview
     8.4.2 Financial Overview
     8.4.3 Product Portfolio
     8.4.4 Business Strategies
8.5 Indian Immunologicals Ltd.
     8.5.1 Company Overview
     8.5.2 Financial Overview
     8.5.3 Product Portfolio
     8.5.4 Business Strategies
8.6 Inova Biotecnologia
     8.6.1 Company Overview
     8.6.2 Financial Overview
     8.6.3 Product Portfolio
     8.6.4 Business Strategies
     8.6.5 Recent Developments
8.7 Intervac (Pvt.) Ltd.
     8.7.1 Company Overview
     8.7.2 Financial Overview
     8.7.3 Product Portfolio
     8.7.4 Business Strategies
8.8 Merial
     8.8.1 Company Overview
     8.8.2 Financial Overview
     8.8.3 Product Portfolio
     8.8.4 Business Strategies
     8.8.5 Recent Developments
8.9 Merck Animal Health
     8.9.1 Company Overview
     8.9.2 Financial Overview
     8.9.3 Product Portfolio
     8.9.4 Business Strategies
     8.9.5 Recent Developments

List of Figures
 
FIG. 1 FMD Vaccines: Market Segmentation
FIG. 2 Global FMD Vaccines Market Revenue, by Types, 2013 (USD Million)
FIG. 3 Global FMD Vaccines Market Revenue, by Applications, 2013 (USD Million)
FIG. 4 Comparative Analysis: Global FMD Vaccines Market, by Geography, 2013 & 2020 (Value %)
FIG. 5 Value Chain Analysis: Global FMD Vaccines Market
FIG. 6 Porter’s Five Forces Analysis: Global FMD Vaccines Market
FIG. 7 Market Attractiveness Analysis: Global Facial Injectables Market, by Geography
FIG. 8 Market Share Analysis: Global FMD Vaccines Market, by Key Players, 2013 (%)
FIG. 9 Global Aluminum Hydroxide/Saponin based Vaccines Market, 2012 – 2020 (USD Million)
FIG. 10 Global Oil based Vaccines Market, 2012 – 2020 (USD Million)
FIG. 11 Global Emergency Vaccines Market, 2012 – 2020 (USD Million)
FIG. 12 Global Cattle Application Market, 2012– 2020 (USD Million)
FIG. 13 Global Pigs Application Market, 2012– 2020 (USD Million)
FIG. 14 Global Sheep and Goats Application Market, 2012– 2020 (USD Million)
FIG. 15 Global Others Application Market, 2012– 2020 (USD Million)
FIG. 16 Bayer AG (Animal Health): Annual Revenue, 2011 – 2013 (USD Million)
FIG. 17 Merial (Animal Health Division of Sanofi): Annual Revenue, 2011 – 2013 (USD Million)
FIG. 18 Merck Animal Health: Annual Revenue, 2011 – 2013 (USD Million)

List of Tables
 
TABLE 1 Market Snapshot: Global FMD Vaccines Market (2013 and 2020)
TABLE 2 Global FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 3 Global Conventional Vaccines Market Revenue, by Adjuvants, 2012 – 2020 (USD Million)
TABLE 4 Global FMD Vaccines Market Revenue, by Applications, 2012 – 2020 (USD Million)
TABLE 5 Global FMD Vaccines Market Revenue, by Geography, 2012 – 2020 (USD Million)
TABLE 6 Europe FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 7 Asia Pacific FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 8 Asia Pacific FMD Vaccines Market Revenue, by Country, 2012 – 2020 (USD Million)
TABLE 9 China FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 10 India FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 11 South Korea FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 12 Malaysia FMD Vaccines Market Revenue, by Country, 2012 – 2020 (USD Million)
TABLE 13 Rest of APAC FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 14 RoW FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 15 RoW FMD Vaccines Market Revenue, by Country, 2012 – 2020 (USD Million)
TABLE 16 Latin America FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 17 Africa FMD Vaccines Market Revenue, by Country, 2012 – 2020 (USD Million)
TABLE 18 South Africa FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 19 Algeria FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 20 Nigeria FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 21 Rest of Africa FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)
TABLE 22 Rest of Row FMD Vaccines Market Revenue, by Types, 2012 – 2020 (USD Million)

 
Foot-and-mouth disease (FMD) is an infection caused by aphthovirus belonging to the family Picornaviridae. FMD is caused by seven different types of serotypes: O, A, C, Asia 1 and Southern African Territories (SAT) 1, 2 and 3. Currently available vaccines are serotype-specific, hence multiple vaccinations are required to cover the antigenic diversity. Cloven-hoofed animals especially cattle, pigs, sheep and goats are susceptible to FMD. The major symptoms of FMD are high fever, sudden weight loss, increased death rate in newborn animals, low conception rate, painful lesions in and around mouth, lips and feet, and excessive salivation. High frequency of FMD outbreaks especially in Asia, the Middle East, and Latin America is fueling the demand for FMD vaccines. In addition, government initiatives to eradicate the disease is resulting in increased awareness about FMD vaccines, thereby driving market growth. This report covers the market analysis of various types of vaccines that are used to control FMD.
 
The executive summary of the report comprises market snapshot of the global foot-and-mouth disease vaccines market and comparative analysis by geography in terms of value % for 2013 and 2020. The global foot-and-mouth disease vaccines market has been segmented based on types of vaccines: conventional and emergency vaccines. The conventional vaccines segment has been sub-segmented based on adjuvants: aluminum hydroxide/saponin and oil-based vaccines. In-depth market analysis and forecast for all the segments mentioned above has been provided in the report, in terms of market revenue (USD million) from 2012 to 2020. The report includes the compounded annual growth rate (CAGR %) for each application segment (cattle, pigs, sheep and goat and others) for the forecast period from 2014 to 2020, considering 2013 as the base year.  
 
The market overview section of the foot-and-mouth disease vaccines market report analyzes the market dynamics and trends such as drivers, restraints and opportunities that influence the current nature and future status of the global FMD vaccine market. Impact factors such as market attractiveness analysis by geography and Porter’s five forces (bargaining power of suppliers, bargaining power of buyers, threat of new entrants, threat of substitutes and competitive rivalry) analysis of the global foot-and-mouth disease vaccines market have been provided in this section of the report. In addition, market share analysis of key players (value %) for the year 2013 has also been explained in the market overview section of the report in order to provide a thorough analysis of the overall competitive scenario in the global FMD vaccines market. Furthermore, the report includes value chain analysis and regulatory framework analysis of the FMD vaccines market. 
 
Geographically, the global FMD vaccines market has been classified into four regions: North America, Europe, Asia Pacific and Rest of the World (RoW). The current and future market sizes (in terms of USD million) of the regional markets mentioned above have been provided in the report for the period from 2012 to 2020 along with the growth rate (CAGR %) for the period from 2014 to 2020. The study further offers recommendations for the foot-and-mouth disease vaccines market, which would be useful for existing and new players to sustain and grow in the market. 
 
The foot-and-mouth disease vaccines market report concludes with the company profiles section that includes key information in terms of company overview, financial information, product portfolio, business strategies and recent development about the major players operating in the FMD vaccines market. Detailed analysis of these companies is included in this section in order to give a thorough analysis of the overall competitive scenario in the global FMD vaccines market. Key players profiled in the section include Agrovet Co., Bayer AG, Biogenesis Bagó, Brilliant Bio Pharma Limited, Indian Immunologicals Ltd., Inova Biotechnologia, Intervac (Pvt.) Ltd., Merial, and Merck Animal Health (MSD). 
 
The global foot and mouth disease vaccines market is segmented as follows:
 
Global Foot and Mouth Disease Vaccines Market, by Types
  • Conventional Vaccines 
    • Aluminum Hydroxide/Saponin
    • Oil Based
  • Emergency Vaccines
Global Foot and Mouth Disease Vaccines Market, by Applications
  • Cattle
  • Pigs
  • Sheep and Goats
  • Others
Global Foot and Mouth Disease Vaccines Market, by Geography
  • North America
  • Europe 
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Malaysia
    • Rest of APAC
  • Rest of the World
    • Latin America
    • Africa
      • South Africa
      • Algeria
      • Nigeria
      • Rest of Africa
    • Rest of RoW


 
 
Back To Top